Dr. Daniel Y. Song
Claim this profileSKCCC at Johns Hopkins
Studies Prostate Cancer
Studies Prostate Adenocarcinoma
3 reported clinical trials
14 drugs studied
Affiliated Hospitals
Clinical Trials Daniel Y. Song is currently running
Hormone + Radiation Therapy
for Prostate Cancer
This phase III trial compares less intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in treating patients with high risk prostate cancer and low gene risk score. This trial also compares more intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in patients with high risk prostate cancer and high gene risk score. Apalutamide may help fight prostate cancer by blocking the use of androgen by the tumor cells. Radiation therapy uses high energy rays to kill tumor cells and shrink tumors. Giving a shorter hormone therapy treatment may work the same at controlling prostate cancer compared to the usual 24 month hormone therapy treatment in patients with low gene risk score. Adding apalutamide to the usual treatment may increase the length of time without prostate cancer spreading as compared to the usual treatment in patients with high gene risk score.
Recruiting2 awards Phase 36 criteria
Focal Brachytherapy
for Prostate Cancer
The Principal Investigator's (PI) working hypothesis is that the PI can utilize the high predictive value of 18F-DCFPyl PSMA to identify clinically significant tumors in patients who will undergo brachytherapy, as well as areas which are uninvolved or contain only clinically insignificant disease. In the PI's clinical trial, the uninvolved regions (as defined by combined PET-MR-biopsy data) will not be targeted and receive only fall-off dose, which we have shown to be associated with reductions in toxicity.
Recruiting1 award Phase < 18 criteria
More about Daniel Y. Song
Clinical Trial Related3 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Daniel Y. Song has experience with
- Flutamide
- Focal Brachytherapy
- (18F)DCFPyL
- Histrelin
- Prednisone
- Abiraterone Acetate
Breakdown of trials Daniel Y. Song has run
Prostate Cancer
Prostate Adenocarcinoma
Bone Metastasis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Daniel Y. Song specialize in?
Daniel Y. Song focuses on Prostate Cancer and Prostate Adenocarcinoma. In particular, much of their work with Prostate Cancer has involved treating patients, or patients who are undergoing treatment.
Is Daniel Y. Song currently recruiting for clinical trials?
Yes, Daniel Y. Song is currently recruiting for 2 clinical trials in Baltimore Maryland. If you're interested in participating, you should apply.
Are there any treatments that Daniel Y. Song has studied deeply?
Yes, Daniel Y. Song has studied treatments such as Flutamide, Focal Brachytherapy, (18F)DCFPyL.
What is the best way to schedule an appointment with Daniel Y. Song?
Apply for one of the trials that Daniel Y. Song is conducting.
What is the office address of Daniel Y. Song?
The office of Daniel Y. Song is located at: SKCCC at Johns Hopkins, Baltimore, Maryland 21287 United States. This is the address for their practice at the SKCCC at Johns Hopkins.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.